In the late-breaking research sessions, Reich presented BE RADIANT, the first Phase III trial to compare inhibition of IL-17A and IL-17F…

Cannabidiol (CBD) comes from Cannabis sativa, which is a medicinal plant known to have several properties. Several types of extracts from…

Current guidelines provide clinical recommendations for asthma and chronic obstructive pulmonary disease (COPD) treatment…

This industry symposium took place on 6th Sept 2021 as part of the virtual European Respiratory Society (ERS) International Congress 2021

THE EUROPEAN Respiratory Society (ERS) International Congress is the world’s largest gathering of respiratory professionals, with over 300 speakers and more than 500 chairs. This year’s congress was planned to take place in Barcelona, Spain; however, for the second year running, the ERS congress occurred virtually due to the COVID-19 pandemic. With guidelines advising against large gatherings and many respiratory professionals being frontline workers, this was the best option, and the silver lining of the virtual congress is that all sessions can be replayed by attendees until December this year.

Bringing together a collection of the most forward-thinking approaches to lung disease, the European Respiratory Society (ERS) International Congress 2021 hosted a virtual session on imaging biomarkers. Four insightful presentations discussed the shift towards more longitudinal imaging approaches for lung disease and provided an overview of quantitative analyses with computer-trained algorithms. Alongside this was a discussion of the use of novel biomarkers such as pleuroparenchymal fibroelastosis.